GLOBOTRIAOSYLCERAMIDE

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting GLOBOTRIAOSYLCERAMIDE:

# Drug Count
0 AGALSIDASE BETA 5
See all common drugs associated with GLOBOTRIAOSYLCERAMIDE

GLOBOTRIAOSYLCERAMIDE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AGALSIDASE BETA 5 0.0005
See all drugs enriched for association with GLOBOTRIAOSYLCERAMIDE

These drug classes are most commonly taken by patients reporting GLOBOTRIAOSYLCERAMIDE:

# Drug class Count
0 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 5
See all common drug classes associated with GLOBOTRIAOSYLCERAMIDE

GLOBOTRIAOSYLCERAMIDE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 5 0.0005
See all drug classes enriched for association with GLOBOTRIAOSYLCERAMIDE